The FDA's advisory board, although it voted positively by a vote of 11-3 that Restanza was safe to take, voted negatively by a vote of 11-3 that the drug was ineffective. To me, this boils down to a drug being safe to take, but it won't do anything to cure ya. Doesn't sound like something that could take off anything soon, but I have to wonder how many will really delve into the background, or simply react on hearing that the drug is up for FDA approval? As mentioned above, the advice of the Advisory board is certainly taken into account, but the final decision is still ultimately the FDA's.dr banner said: Bret, your thoughts on ADLS??
Your decision on how you wish to proceed on this one, but my gut feeling says the FDA won't approve it, but the stock could sure rise before that decision is made, much as it did prior to the news release on June 3rd that the advisory board had negative vibes about it, and the price dropped like a rock. So, based on that, it might possibly be a good time to get into it and plan a quick escape just after it makes the jump up, because if the drug is turned down, the stock will fall hard. :)
Final thought.. the stock has been making a slow uphill movement since the last big drop and could certainly go higher. It closed at .60 on Friday with a volume of just over 1 1/2 million, so there is interest there. As much as I hate to drop back down into Penny Stock land, I do believe it will track northward, so come Monday I most likely will spend a few pennies on it knowing full well that I will dump it if it does make that sudden jump up just before July 31. Might be too late after the news......orrrrrrr.. it could get approved and really jump. I will go with gut and dump. ;)
